AR043370A1 - Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga - Google Patents
Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -drogaInfo
- Publication number
- AR043370A1 AR043370A1 ARP040100567A ARP040100567A AR043370A1 AR 043370 A1 AR043370 A1 AR 043370A1 AR P040100567 A ARP040100567 A AR P040100567A AR P040100567 A ARP040100567 A AR P040100567A AR 043370 A1 AR043370 A1 AR 043370A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- pharmaceutical compositions
- oral administration
- drug interaction
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H35/00—Delivering articles from cutting or line-perforating machines; Article or web delivery apparatus incorporating cutting or line-perforating devices, e.g. adhesive tape dispensers
- B65H35/0006—Article or web delivery apparatus incorporating cutting or line-perforating devices
- B65H35/0073—Details
- B65H35/008—Arrangements or adaptations of cutting devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H35/00—Delivering articles from cutting or line-perforating machines; Article or web delivery apparatus incorporating cutting or line-perforating devices, e.g. adhesive tape dispensers
- B65H35/0006—Article or web delivery apparatus incorporating cutting or line-perforating devices
- B65H35/002—Hand-held or table apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65H—HANDLING THIN OR FILAMENTARY MATERIAL, e.g. SHEETS, WEBS, CABLES
- B65H2301/00—Handling processes for sheets or webs
- B65H2301/50—Auxiliary process performed during handling process
- B65H2301/51—Modifying a characteristic of handled material
- B65H2301/515—Cutting handled material
- B65H2301/5153—Details of cutting means
- B65H2301/51532—Blade cutter, e.g. single blade cutter
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composición farmacéutica de administración oral de un inhibidor de trombina entre otros que previene una disminución en la biodisponibilidad de una droga luego de la ingesta de alimentos, que comprende: i) dicha droga, y ii) un polímero bioadhesivo farmacéuticamente aceptable, para prevenir la disminución en el grado de absorción de la droga debido a una interacción con enzimas digestivas o ingredientes alimenticios luego de la ingesta de alimentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030011392 | 2003-02-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043370A1 true AR043370A1 (es) | 2005-07-27 |
Family
ID=32906553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100567A AR043370A1 (es) | 2003-02-24 | 2004-02-24 | Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040229821A1 (es) |
KR (1) | KR20040076203A (es) |
AR (1) | AR043370A1 (es) |
TW (1) | TW200420304A (es) |
WO (1) | WO2004073747A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7167686B2 (en) * | 2002-01-25 | 2007-01-23 | Qualcomm Incorporated | Wireless communications transceiver: transmitter using a harmonic rejection mixer and an RF output offset phase-locked loop in a two-step up-conversion architecture and receiver using direct conversion architecture |
US7097967B2 (en) * | 2002-10-24 | 2006-08-29 | Lg Life Sciences Ltd. | Method of predicting drug-food interaction |
PL1891089T3 (pl) * | 2005-06-02 | 2015-05-29 | Merck Sharp & Dohme | Inhibitory proteazy HCV w połączeniu z pokarmem |
AR062057A1 (es) * | 2006-07-17 | 2008-10-15 | Boehringer Ingelheim Int | Uso de los inhibidores directos de la trombina |
EA200900091A1 (ru) * | 2006-07-17 | 2009-06-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний |
TW200824723A (en) * | 2006-09-12 | 2008-06-16 | Glaxo Group Ltd | Pharmaceutical composition |
EP1923053A1 (en) * | 2006-09-27 | 2008-05-21 | Novartis AG | Pharmaceutical compositions comprising nilotinib or its salt |
CN103070844A (zh) * | 2013-01-28 | 2013-05-01 | 万平 | 一种定位速释生物粘附剂及其应用 |
US9596622B2 (en) * | 2014-01-31 | 2017-03-14 | Cable Television Laboratories, Inc. | Mesh networking of access points for load balancing |
GB2542064B (en) * | 2015-01-20 | 2020-11-18 | Univ California | Unit aerosol doses for anticoagulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5007790A (en) * | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
AU2447097A (en) * | 1996-04-10 | 1997-10-29 | Merck & Co., Inc. | Oral coated active drugs |
GB9910773D0 (en) * | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
US6338857B1 (en) * | 2000-05-26 | 2002-01-15 | Pharma Pass Llc | Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release |
-
2004
- 2004-02-13 KR KR1020040009746A patent/KR20040076203A/ko not_active Application Discontinuation
- 2004-02-16 TW TW093103598A patent/TW200420304A/zh unknown
- 2004-02-23 US US10/782,951 patent/US20040229821A1/en not_active Abandoned
- 2004-02-23 WO PCT/KR2004/000366 patent/WO2004073747A1/en active Application Filing
- 2004-02-24 AR ARP040100567A patent/AR043370A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20040229821A1 (en) | 2004-11-18 |
TW200420304A (en) | 2004-10-16 |
WO2004073747A1 (en) | 2004-09-02 |
KR20040076203A (ko) | 2004-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012358A1 (es) | Formulaciones de liberacion prolongada de derivados de eritromicina y su uso para la manufactura de un medicamento | |
CO5170471A1 (es) | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio | |
AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
NO20045140L (no) | Blandinger og fremgangsmate for transmukosal legemiddelavlevering og kryobeskyttelse | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
DK1471890T3 (da) | Farmaceutisk doseringsform til mukös afgivelse | |
CO5640087A2 (es) | Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos | |
AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
AR109644A2 (es) | Pradofloxacina y composición farmacéutica para el tratamiento sistémico de enfermedades bacterianas en la cavidad bucal | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
UY25544A1 (es) | Forma de dosificación de nefazodona | |
DE60313359D1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
AR043370A1 (es) | Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga | |
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
HUP0000137A2 (hu) | Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény | |
BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
DK1517677T3 (da) | Poppende oral administrationsform | |
AR030957A1 (es) | Composiciones de analgesico y glucosamina | |
BRPI0412364A (pt) | composição farmacêutica sólida, compreendendo amisulpride | |
PE20030830A1 (es) | Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |